Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Canopy Growth Corp Director's Dealing 2020

Jun 3, 2020

32768_dirs_2020-06-03_3f1e572a-7df6-4e1f-881d-75b9171c36b1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Canopy Growth Corp (CGC)
CIK: 0001737927
Period of Report: 2020-04-01

Reporting Person: Kovacevic Rade Nikola (President)

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 293119 Direct
Common Shares 5319 Indirect
Common Shares 4314 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $11.71 2023-02-27 Common Shares (13333) Direct
Stock Option $8.18 2023-06-28 Common Shares (73333) Direct
Stock Option $27.99 2024-02-15 Common Shares (60000) Direct
Stock Option $36.34 2024-12-24 Common Shares (100000) Direct
Stock Option $27.85 2025-12-12 Common Shares (32315) Direct

Footnotes

F1: The options are fully vested.

F2: The options were granted on June 28, 2017 and vest on the third anniversary of the grant date.

F3: The options were granted on February 15, 2018 and vest in three equal annual installments on the first, second and third anniversaries of the grant date.

F4: The options were granted on December 24, 2018 and vest in three equal annual installments on the first, second and third anniversaries of the grant date.

F5: On December 12, 2019, the reporting person was granted an option to purchase 96,946 shares of common shares. The option vests in three equal annual installments beginning on the second anniversary of the grant date based on satisfaction of certain performance criteria. The first of the performance criteria is tied directly to the market price of the common shares, and as such 32,315 options are reportable as of the date of this Form 3. The other options are subject to performance criteria that have not been met and therefore are not reported in Table II.

F6: The exercise price is expressed in Canadian dollars.